Omega Healthcare Posts Strong Q3 Results and Expands in UK Market
Key Facts
Omega Healthcare Investors recorded an 82.7% occupancy rate and improved its EBITDAR coverage to 1.67x during the third quarter of 2026. Seeking Alpha reported that the company's leverage dropped to a historic low of 3.1x during the period. Additionally, the firm executed a significant $845 million mortgage loan in the United Kingdom at an interest rate of 8.72%.
OHI closed at $47.53 on November 3, 2026, with the stock trading between a day low of $46.82 and a high of $47.66. This performance coincides with strategic international diversification, particularly in the UK market, which recently saw mortgage approval and lending data released on October 29, 2026.
Investors are awaiting the UK interest rate decision from the Bank of England on November 5, 2026, an event that may impact the company's international financing costs. The UK Construction PMI is also due on the same day, with a forecast of 46.1.